ورود
مقالات فارسیISIکنفرانسهاژورنالها

Clinical Manifestations and Outcomes of COVID-۱۹ in Diabetes Mellitus People, Yazd, Iran-۲۰۲۱

محل انتشار: مجله دیابت و چاقی ایران، دوره: 15، شماره: 4
سال انتشار: 1402
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 65

فایل این مقاله در 7 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:
https://civilica.com/doc/1878832

شناسه ملی سند علمی:

JR_IJDO-15-4_001

تاریخ نمایه سازی: 18 دی 1402

چکیده مقاله:

Objective: Diabetes mellitus is reported to be the third most prevalent comorbidity with COVID-۱۹, after cardio‐cerebrovascular disease and hypertension. Furthermore, diabetes increases the likelihood of admission to the hospital and intensive care unit and death from COVID-۱۹. The aim of the present study was to compare the clinical manifestations and outcomes of COVID-۱۹ in diabetic versus non-diabetic inpatients. Materials and Methods: The medical records of ۶۵۲۵ patients with definitive diagnosis of COVID-۱۹ were obtained from the reference COVID-۱۹ diagnosis laboratory from January to July ۲۰۲۱ in Yazd, Iran. Patients were investigated for data on onset, clinical history, and fatality rate. COVID-۱۹-related death was defined as positive RT-PCR in at least one of three nasal samples. Data were analysed using SPSS ۲۴. Results: Among inpatients, ۲۱.۲% were diabetic. The mean ages of diabetic and non-diabetic patients were ۶۴.۴۵ (±۱۳.۸۷) and ۵۲.۹۸ (±۲۰.۳۶) years, respectively. Diabetics were more likely to be admitted to the intensive care unit (۶.۸% vs. ۵%, P= ۰.۰۲) and the fatality rate was higher among them than non-diabetics (۲۲.۶% vs. ۱۲%, P< ۰.۰۰۱). In diabetics, the mean age of non-survivors was lower than that of survivors (۶۲.۵۷ vs. ۷۰.۴۸, P= ۰.۰۰۰۱) and the frequency of death was higher among men than women (۵۳% vs. ۴۷.۵%, P= ۰.۰۴۵). Generally, diabetes has the strongest association with COVID-۱۹ death (P= ۰.۰۰۰۱). Conclusion: Diabetic patients experience more adverse outcomes because of COVID-۱۹. These findings indicate the need for special attention in relation to prevention treatment against COVID-۱۹ in patients with diabetes.

کلیدواژه ها:

COVID-۱۹ ، Diabetes ، Inpatients ، Outcomes

نویسندگان

Akram Mehrabbeik

Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd. Iran.

Mohsen Mirzaei

Yazd Cardiovascular Research Centre, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Maryam Askari

Genetic and Environmental Adventures Research Center, School of Abarkouh Paramedicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Mohamad Ali Sahami

Yazd Health Network, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Mozhgan Minoosepehr

Health Department, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Nasim Namiranian

Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd. Iran.

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Farnoosh G, Alishiri G, Hosseini Zijoud S, Dorostkar R, Jalali ...
  • Mahase E. Covid-۱۹: WHO declares pandemic because of "alarming levels" ...
  • Organization WHO. WHO COVID-۱۹ Dashboard. World Health Organization;۲۰۲۲. https://covid۱۹.who.int/ ...
  • Chen N, Zhou M, Dong X, Qu J, Gong F, ...
  • Bai Y, Yao L, Wei T, Tian F, Jin DY, ...
  • Atlas D. International diabetes federation. IDF Diabetes Atlas, ۷th edn. ...
  • Li B, Yang J, Zhao F, Zhi L, Wang X, ...
  • Ansari K, Mousavi SA, Cheraghipour M, AkhoundiMeybodi Z. Comorbidity of ...
  • Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, ...
  • Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, ...
  • Yang X, Yu Y, Xu J, Shu H, Liu H, ...
  • Jafar N, Edriss H, Nugent K. The effect of short-term ...
  • Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, ...
  • Cuschieri S, Grech S. COVID-۱۹ and diabetes: The why, the ...
  • Pugliese G, Vitale M, Resi V, Orsi E. Is diabetes ...
  • Xie J, Tong Z, Guan X, Du B, Qiu H. ...
  • Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, ...
  • Feldman EL, Savelieff MG, Hayek SS, Pennathur S, Kretzler M, ...
  • Kim M, Budd N, Batorsky B, Krubiner C, Manchikanti S, ...
  • Gupta A, Nayan N, Nair R, Kumar K, Joshi A, ...
  • Kumar A, Arora A, Sharma P, Anikhindi SA, Bansal N, ...
  • COVID C, Team R, Chow N, Fleming-Dutra K, Gierke R, ...
  • Wang D, Hu B, Hu C, Zhu F, Liu X, ...
  • Sardu C, Gargiulo G, Esposito G, Paolisso G, Marfella R. ...
  • Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, ...
  • Peric S, Stulnig TM. Diabetes and COVID-۱۹: disease-management-people. Wiener Klinische ...
  • Zhu L, She ZG, Cheng X, Qin JJ, Zhang XJ, ...
  • Yan Y, Yang Y, Wang F, Ren H, Zhang S, ...
  • Zhang Y, Cui Y, Shen M, Zhang J, Liu B, ...
  • Hadjadj S, Saulnier PJ, Ruan Y, Zhu X, Pekmezaris R, ...
  • Petrilli CM, Jones SA, Yang J, Rajagopalan H, O'Donnell L, ...
  • Rayman G, Lumb A, Kennon B, et al. Guidelines for ...
  • Nafakhi H, Alareedh M, Al-Buthabhak K, et al. Predictors of ...
  • Barron E, Bakhai C, Kar P, et al. Associations of ...
  • Wray S, Arrowsmith S. The Physiological Mechanisms of the Sex-Based ...
  • Deiana G, Azara A, Dettori M, et al. Deaths in ...
  • Li Lq, Huang T, Wang Yq, et al. COVID‐۱۹ patients' ...
  • Zhao Y, Zhao Z, Wang Y, et al. Single-cell RNA ...
  • Ma R, Holt R. COVID‐۱۹ and diabetes. Diabetic Medicine. ۲۰۲۰ ...
  • Ceriello A. Management of diabetes today: An exciting confusion. Diabetes ...
  • Guo A-X, Cui J-J, OuYang Q-Y, et al. The clinical ...
    • نمایش کامل مراجع